Therefore, in addition to overall and subgroup analyses, we evaluated the risk of rs1447295 with different prostate cancer clinical characteristics, including Gleason score, tumor stage and PSA level, and detailed results were shown in Table 3 and 4. The gene discussed is KLK3; the disease is neoplasm.